Real-time enrollment status for this endometrial cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 1:39 PM UTC
| NCT Number | NCT06952504 |
| Recruiting Status | Recruiting |
| Condition | Endometrial Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 1,123 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | February 20, 2026 (1 week ago) |
As of March 2, 2026: Clinical trial NCT06952504 is currently recruiting participants. This clinical trial study for endometrial cancer is actively seeking new participants at 20 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06952504 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06952504 was last updated 1 week ago (February 20, 2026). HelloStudys verifies this status automatically.